Form 4: Alignment Healthcare Director Plans Sale of 25,000 Shares Under 10b5-1 Plan

Alignment Healthcare Director Joseph S. Konowiecki filed a Form 4 indicating a planned sale of 25,000 common shares at $16 per share on July 31, 2025, under a Rule 10b5-1 plan.

Summary

• Joseph S. Konowiecki, a Director of Alignment Healthcare, Inc. (ALHC), reported a planned sale of common stock.
• The transaction involves the disposition of 25,000 shares at a price of $16.00 per share.
• The sale is scheduled for July 31, 2025, and is being conducted under a Rule 10b5-1 trading plan adopted on March 5, 2025.
• Following this transaction, Konowiecki will beneficially own 1,152,049 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The filing reports a director's planned sale of shares, which, while pre-scheduled under a 10b5-1 plan, is a routine disclosure and does not significantly alter the overall sentiment towards the company.

Positives

• The transaction is being conducted under a Rule 10b5-1 plan, which indicates the sale was pre-scheduled and not based on new material non-public information, enhancing transparency and reducing concerns about opportunistic insider trading.

Negatives

• The planned sale by a director represents a reduction in insider ownership, which some investors may perceive as a slight negative.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may note a reduction in insider ownership, though the pre-planned nature of the sale under a Rule 10b5-1 plan suggests it is not based on new material non-public information.

Key Dates

Keywords

SEC Form 4, Insider Transaction, Stock Sale, Director, Alignment Healthcare, ALHC, Joseph S. Konowiecki, Rule 10b5-1 Plan